Insider Trading › IBRX › Insiders
ImmunityBio, Inc.
IBRX·Nasdaq·
United States·Insider activity
$9.69
-0.69 (-6.65%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
IBRX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
IBRXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, IBRX insiders filed 0 purchases ($0) and 8 sales ($5.0M) on the open market, by 3 insiders. Newest filing Oct 6, 2026 (yesterday).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by IBRX insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$5.0MSales · 180 days
32Open-market transactions on record
3Insiders filing · 180 days
Purchases (code P) and sales (code S) of IBRX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
32 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Simon Barry J.Director · Director | Sale | −25.0K | $10.75 | $269K | 2.8Mdirect | Oct 5, 2026 | Oct 6, 2026 | Form 4 ↗ |
| Cohen CherylDirector · Director | Sale | −81.1K | $10.50 | $851K | 100.3Kdirect | Oct 2, 2026 | Oct 6, 2026 | Form 4 ↗ |
| Cohen CherylDirector · Director | Sale | −131.2K | $9.50 | $1.2M | 125.4Kdirect | Jul 2, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector · Director | Sale | −159.5K | $9.02 | $1.4M | 0direct | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector · Director | Sale | −1,000 | $9.00 | $9K | 0direct | Jun 30, 2026 | Jul 1, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector · Director | Sale | −95.7K | $9.01 | $862K | 0direct | Jun 29, 2026 | Jul 1, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −25.0K | $7.88 | $197K | 2.8Mdirect | Jun 24, 2026 | Jun 26, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −23.0K | $7.18 | $165K | 2.8Mdirect | Jun 4, 2026 | Jun 5, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −75.0K | $12.01 | $901K | 2.9Mdirect | Feb 24, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector | Sale | −25.0K | $10.00 | $250K | 0direct | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −165.0K | $10.25 | $1.7M | 2.9Mdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −10.0K | $9.25 | $93K | 3.1Mdirect | Feb 20, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector | Sale | −25.0K | $7.51 | $188K | 0direct | Jan 20, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −75.0K | $7.88 | $591K | 3.1Mdirect | Jan 20, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −77.0K | $6.54 | $503K | 3.2Mdirect | Jan 20, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Selecky ChristobelDirector | Sale | −50.0K | $5.00 | $250K | 0direct | Jan 16, 2026 | Jan 21, 2026 | Form 4 ↗ |
| BLASZYK MICHAEL DDirector | Purchase | +485 | $2.75 | $1K | 71.9Kindirect | Jun 5, 2023 | Jun 5, 2023 | Form 4 ↗ |
| BLASZYK MICHAEL DDirector | Purchase | +48.0K | $2.77 | $133K | 71.4Kindirect | Jun 5, 2023 | Jun 5, 2023 | Form 4 ↗ |
| BLASZYK MICHAEL DDirector | Purchase | +23.4K | $2.72 | $64K | 23.4Kindirect | Jun 5, 2023 | Jun 5, 2023 | Form 4 ↗ |
| Brennan John OwenDirector | Purchase | +10.0K | $2.90 | $29K | 25.0Kdirect | Jun 2, 2023 | Jun 5, 2023 | Form 4 ↗ |
| Brennan John OwenDirector | Purchase | +10.0K | $2.80 | $28K | 15.0Kdirect | Jun 2, 2023 | Jun 5, 2023 | Form 4 ↗ |
| Brennan John OwenDirector | Purchase | +5,000 | $2.74 | $14K | 5,000direct | Jun 2, 2023 | Jun 5, 2023 | Form 4 ↗ |
| Clark WesleyDirector | Purchase | +7,000 | $2.91 | $20K | 8,000direct | Jun 1, 2023 | Jun 5, 2023 | Form 4 ↗ |
| Adcock RichardCEO & President · Director | Purchase | +1,923 | $8.81 | $17K | 1,930indirect | Oct 8, 2021 | Oct 8, 2021 | Form 4 ↗ |
| Adcock RichardCEO & President · Director | Purchase | +7 | $9.00 | $63 | 7indirect | Oct 8, 2021 | Oct 8, 2021 | Form 4 ↗ |
| Cohen CherylDirector | Sale | −14.8K | $10.12 | $150K | 200.6Kdirect | Aug 23, 2021 | Aug 24, 2021 | Form 4 ↗ |
| Cohen CherylDirector | Sale | −9,976 | $10.00 | $100K | 215.4Kdirect | Aug 20, 2021 | Aug 24, 2021 | Form 4 ↗ |
| Cohen CherylDirector | Sale | −2,133 | $10.03 | $21K | 225.4Kdirect | Aug 18, 2021 | Aug 19, 2021 | Form 4 ↗ |
| Cohen CherylDirector | Sale | −43.4K | $10.12 | $439K | 227.5Kdirect | Aug 17, 2021 | Aug 19, 2021 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −88.8K | $16.18 | $1.4M | 3.1Mdirect | May 25, 2021 | May 25, 2021 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −21.2K | $16.02 | $340K | 3.2Mdirect | May 24, 2021 | May 25, 2021 | Form 4 ↗ |
| Simon Barry J.Director | Sale | −15.0K | $16.09 | $241K | 3.2Mdirect | May 21, 2021 | May 25, 2021 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →
